Clinical trial will focus on immune response in younger adults
Drugmakers seeking to maintain protection afforded by shots
Read the full article here: https://www.bloomberg.com/news/articles/2022-01-25/pfizer-biontech-begin-study-of-omicron-specific-covid-vaccine
Comments